Aim: The present study aimed to synthesize and characterize carbon nanoparticles (CNPs) from a new precursor and to evaluate its effect on the viability of healthy seeds and cell lines. Methodology: The CNPs were synthesized by acid assisted carbonization of carbohydrate and its characteristics such as size, fluorescence property and purity of samples were evaluated for confirmation. Cytotoxic studies were performed in MCF 10a cell lines using 3-4,5-dimethylthiazol-2,5-diphenyltetrazolium bromide (MTT) assay whereas the phytotoxic assay was conducted by using scallions and Indian pearl millet. Results: Transmission electron microscope (TEM) results showed that nano-sized CNPs [10-40 nm] were synthesized and its characteristic peaks were observed in Ultraviolet (UV) and fluorescence spectrum. The Energy Dispersive X-ray (EDAX) analysis confirmed the presence of carbon and oxygen without any impurities. It was non-cytotoxic for healthy MCF 10a cell lines and did not affect the germination rate of Indian pearl millets at higher concentrations. In both toxicity studies, the viability of cells and plants was >95% even after exposure to a high concentration of CNPs. Interpretation: The non-cytotoxic and non-phytotoxic nature of CNPs implies that it does not affect the growth of plants, seedling germination and healthy cell lines. It can be considered as a compatible and safe material for MCF 10a cell lines and plants.
Background: Solid lipid nanoparticles (SLN) have drawn increasing interest in recent years. These nanoparticles are formed from stable or solid lipid mixtures and then stabilized by emulsifiers. As nanoparticles, colloidal particles running in size somewhere in the 10 to 1000 nm range are known. SLN provides fascinating properties, such as minimal scale, massive surface area, high medication piling, correspondence of stages at the interface, and is interested in their ability to enhance drug execution. Main text: This paper provides a description of the choice of ingredients, the effect of lipids and their structure on the formulation, and the various methods of processing SLN. We explain the characteristics of SLN stability and the possibilities of SLN stabilization by lyophilization in this article. The relation between drug absorption and the complexity of SLN dispersions, which involves the existence of other colloidal structures and the physical state of the lipid, is uncommonly considered. We define the possible problems of SLN preparation and performance on the basis of characterization. First, the nasal route was known to accomplish the avoidance of first-pass hepatic metabolism in order to maximize absolute bioavailability, and secondly, the immediate nose-to-brain pathway to enhance the delivery of brain medicines. SLNs have been designated to increase drug permeability through the blood-brain barrier as a drug delivery device (BBB). Conclusion: To sum up, this article gives insight SLNs a colloidal drug carrier places together the compensations of polymeric nanoparticles, SLNs have numerous benefits such as easy incorporation of lipid and lipophilic as well as hydrophilic drugs, suitable physical stability, and available at low cost and easy to manufacture. The nasal route was accepted to exploit first its prevention of the hepatic first-pass metabolism to increase the absolute bioavailability, and second, the direct nose-to-brain pathway to enhance the brain drug delivery. SLNs were chosen as a drug delivery system to improve drug permeability across the blood-brain barrier (BBB) and consequently its brain delivery.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.